Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Omnicell (OMCL) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Omnicell (OMCL) over the last 16 years, with Q3 2025 value amounting to $180.1 million.

  • Omnicell's Cash & Equivalents fell 6843.83% to $180.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $180.1 million, marking a year-over-year decrease of 6843.83%. This contributed to the annual value of $369.2 million for FY2024, which is 2111.09% down from last year.
  • According to the latest figures from Q3 2025, Omnicell's Cash & Equivalents is $180.1 million, which was down 6843.83% from $399.0 million recorded in Q2 2025.
  • In the past 5 years, Omnicell's Cash & Equivalents registered a high of $614.2 million during Q2 2021, and its lowest value of $180.1 million during Q3 2025.
  • Its 5-year average for Cash & Equivalents is $406.8 million, with a median of $399.0 million in 2025.
  • In the last 5 years, Omnicell's Cash & Equivalents skyrocketed by 42657.09% in 2021 and then tumbled by 6843.83% in 2025.
  • Quarter analysis of 5 years shows Omnicell's Cash & Equivalents stood at $349.1 million in 2021, then fell by 5.35% to $330.4 million in 2022, then surged by 41.66% to $468.0 million in 2023, then fell by 21.11% to $369.2 million in 2024, then tumbled by 51.22% to $180.1 million in 2025.
  • Its Cash & Equivalents was $180.1 million in Q3 2025, compared to $399.0 million in Q2 2025 and $386.8 million in Q1 2025.